Short Summary
The PTAB granted institution for IPR2025-01598, allowing Medtronic to challenge Moskowitz Family LLC's patent 9005293 at the merits stage.
Detailed Summary
In this Institution Decision, the Patent Trial and Appeal Board (PTAB) granted institution for Inter Partes Review IPR2025-01598. After reviewing the non-discretionary considerations, the Board found that Medtronic, Inc., the petitioner, demonstrated a reasonable likelihood of prevailing on at least one claim challenged against Moskowitz Family LLC's patent 9005293. This decision moves the case forward to the merits phase.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Medtronic, Inc. vs Moskowitz Family LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
BTL Industries, Inc.vsInMode Ltd.
ThermiGen settled its patent infringement lawsuit with Viveve Medical, securing a non‑exclusive license and agreeing to pay royalties. The settlement resolves the 2016 litigation and allows Thermi to continue developing its temperature‑controlled RF platforms for women's intimate health.
Samsung Electronics Co. Ltd. et al.vsMobile Data Technologies LLC
Samsung Electronics has filed an IPR petition seeking to invalidate 21 claims of Mobile Data Technologies’ ’578 patent covering mobile content‑sharing functionality. The petition relies on obviousness over a combination of prior‑art references and argues against discretionary denial.
iRhythm, Inc.vsWelch Allyn, Inc. et al.
iRhythm Technologies filed a Request for Director Review challenging the USPTO’s denial of five IPR petitions on the basis of a new “settled expectations” rule. The petitioner contends the rule is retroactive, violates precedent, and would harm patent quality. The request seeks vacatur of the denial and institution of the IPRs.
Zhuhai CosMX Battery Co., Ltd.vsNingde Amperex Technology Ltd.
The PTAB denied Zhuhai CosMX Battery’s petition to invalidate Ningde Amperex’s 2020 electrolyte patent, finding no reasonable likelihood of success. The Board held that the prior art did not adequately disclose all claim elements, especially the propyl propionate ratio.
Eoptolink Technology USA Inc. et al.vsApplied Optoelectronics, Inc.
Eoptolink has filed an IPR petition seeking cancellation of eight claims of Applied Optoelectronics’ ’887 patent, asserting that the claimed stepped‑profile substrate and edge‑mounted TOSA modules are anticipated or obvious over prior patents by Kuhara and Ho.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.